Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-12-17
pubmed:abstractText
Even though adverse event (AE) collection and official accounting are mandatory for clinical trials, there are limited detailed guidelines specifying how to summarize the event for reporting in a timely and expeditious manner. This article details the AE and serious adverse event (SAE) reporting summary developed for a large multi-center National Institutes of Health (NIH)-sponsored clinical trial.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/K24AA13736, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00042, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00043, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00051, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00065, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00633, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00827, http://linkedlifedata.com/resource/pubmed/grant/M01RR-01066, http://linkedlifedata.com/resource/pubmed/grant/M01RR-06192, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1740-7753
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
618-27
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19889888-Adverse Drug Reaction Reporting Systems, pubmed-meshheading:19889888-Antiviral Agents, pubmed-meshheading:19889888-Automatic Data Processing, pubmed-meshheading:19889888-Carcinoma, Hepatocellular, pubmed-meshheading:19889888-Database Management Systems, pubmed-meshheading:19889888-Disease Progression, pubmed-meshheading:19889888-Hepatitis C, Chronic, pubmed-meshheading:19889888-Humans, pubmed-meshheading:19889888-Interferon-alpha, pubmed-meshheading:19889888-Liver Cirrhosis, pubmed-meshheading:19889888-Liver Failure, pubmed-meshheading:19889888-Liver Neoplasms, pubmed-meshheading:19889888-Multicenter Studies as Topic, pubmed-meshheading:19889888-National Institutes of Health (U.S.), pubmed-meshheading:19889888-Polyethylene Glycols, pubmed-meshheading:19889888-Randomized Controlled Trials as Topic, pubmed-meshheading:19889888-Recombinant Proteins, pubmed-meshheading:19889888-Research Design, pubmed-meshheading:19889888-United States
pubmed:year
2009
pubmed:articleTitle
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial.
pubmed:affiliation
New England Research Institutes, Watertown, MA 02472, USA. mbell@neriscience.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural